Indivior PLC (INDV)
35.38
+0.16
(+0.45%)
USD |
NASDAQ |
Dec 16, 16:00
35.37
-0.01
(-0.03%)
After-Hours: 20:00
Indivior Research and Development Expense (Annual): 107.00M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Viatris, Inc. | 802.90M |
| Pfizer Inc. | 10.74B |
| Iovance Biotherapeutics, Inc. | 282.34M |
| Travere Therapeutics, Inc. | 217.50M |
| Xenetic Biosciences, Inc. | 2.584M |